COVAC-1
/ University of Saskatchewan
- LARVOL DELTA
Home
Next
Prev
1 to 4
Of
4
Go to page
1
December 05, 2024
A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults
(clinicaltrials.gov)
- P1 | N=47 | Completed | Sponsor: University of Saskatchewan | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases
June 02, 2023
A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults
(clinicaltrials.gov)
- P1 | N=47 | Active, not recruiting | Sponsor: University of Saskatchewan | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • CD4 • CD8 • IFNG
March 27, 2023
A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: University of Saskatchewan | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • CD4 • CD8 • IFNG
January 20, 2023
A Clinical Trial to Study the COVAC-1 Booster Dose in Generally Healthy Adults
(clinicaltrials.gov)
- P1 | N=48 | Not yet recruiting | Sponsor: University of Saskatchewan
New P1 trial • Infectious Disease • Novel Coronavirus Disease • Respiratory Diseases • CD4 • CD8 • IFNG
1 to 4
Of
4
Go to page
1